Serotype distribution of invasive pneumococcal disease during the first 60 days of life (Q39872951)

15 September 2017

Serotype distribution of invasive pneumococcal disease during the first 60 days of life (English)

1 reference

15 September 2017

2

0 references

author name string

Matthias Imöhl

series ordinal

1

1 reference

15 September 2017

Christina Mutscher

series ordinal

3

1 reference

15 September 2017

Ralf René Reinert

series ordinal

4

1 reference

15 September 2017

language of work or name

English

0 references

publication date

14 May 2010

1 reference

15 September 2017

1 reference

15 September 2017

28

1 reference

15 September 2017

4758-4762

1 reference

15 September 2017

30

1 reference

Pneumococcus: the first one hundred years.

15 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Temporal and Geographic Stability of the Serogroup‐Specific Invasive Disease Potential of Streptococcus pneumoniae in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Prospects for prevention of childhood infections by maternal immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

7 January 2021

Maternal immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

7 January 2021

Maternal immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Association of serotypes of Streptococcus pneumoniae with age in invasive pneumococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Increased prevalence of pediatric pneumococcal serotypes in elderly adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Antibiotic susceptibility and serotype distribution of 240 Streptococcus pneumoniae causing meningitis in Belgium 1997-2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994--2007.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Streptococcus pneumoniaeInfections in the Neonate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Morbidity and mortality of pneumococcal meningitis and serotypes of causative strains prior to introduction of the 7-valent conjugant pneumococcal vaccine in England

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vacc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Declining invasive pneumococcal disease mortality in the United States, 1990-2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Phase 1 trial of 13-valent pneumococcal conjugate vaccine in Japanese adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Serotype-specific penicillin resistance of Streptococcus pneumoniae in Germany from 1992 to 2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001-2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

Pneumococcal conjugate vaccines--a European perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.097

10.1016/J.VACCINE.2010.04.097

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference